Magnitude of end-stage renal disease in IDDM: A 35 year follow-up study

Kidney International

Volumn 50, Issue 6, 1996, Pages 2041-2046

  Krolewski, Martin ^b   Eggers, Paul W ^b   Warram, James H ^a  

^a JOSLIN DIABETES CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0029960590     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.527     Document Type: Article

References (24)

1. ANDERSEN AR, CHRISTIANSEN JS, ANDERSEN JK, KREINER S, DECKERT T: Diabetic nephropathy in type I (insulin-dependent) diabetes: An epidemiological study. Diabetologia 25:496-501, 1983
2. KROLEWSKI AS, WARRAM JH, CHRISTLIEB AR, BUSICK EJ, KAHN CR: The changing natural history of nephropathy in Type 1 diabetes. Am J Med 78:785-794, 1989
3. KROLEWSKI AS, KOSINSKI EJ, WARRAM JH, LELAND OS, BUSICK EJ, ASMAL AC, RAND LI, CHRISTLIEB AR, BRADLEY RF, KAHN CR: Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 59:750-755, 1987
4. COLE RA, SOELDNER JS, DUNN PJ, BUNN HF: A rapid method for the determination of glycosylated hemoglobins using high pressure liquid chromatography. Metabolism 27:289-301, 1978
5. MOGENSEN CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285:685-688, 1982
6. PARVING H-H, ANDERSEN AR, SMIDT UM, SVENDSEN PA: Early aggressive antihypertensive treatment reduces rate of decline in kidney function. Lancet i:1175-1179, 1983
7. TEUTSCH S, NEWMAN J, EGGERS P: The problem of diabetic renal failure in the United States: An overview. Am J Kid Dis 13:11-13, 1989
8. SIEGAL JE, KROLEWSKI AS, WARRAM JH, WEINSTEIN MC: Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitus. J Am Soc Nephrol 3(Suppl 4):S111-S119, 1992
9. KIBERD BA, JINDAL KK: Screening to prevent renal failure in insulin dependent diabetic patients: An economic evaluation. Br Med J 311:1595-1549, 1995
10. DCCT RESEARCH GROUP: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
11. LEWIS EJ, HUNSICKER LG, BAIN RP, ROHDE RD, FOR THE COLLABORATIVE STUDY GROUP: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
12. VIBERTI GC, MOGENSEN CE, GROOP LC, PAULS JF, FOR THE EUROPEAN MICROALBUMINURIA CAPTOPRIL STUDY GROUP: Effect of captpril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 271:275-279, 1994
13. LAFFEL LMB, MCGILL JB, GANS DJ, ON BEHALF OF THE NORTH AMERICAN MICROALBUMINURIA STUDY GROUP: The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. Am J Med 94:497-504, 1995
14. CHRISTLIEB AR: Diabetes and hypertensive vascular disease: Mechanisms and treatment. Am J Cardiol 32:592-606, 1973
15. LEE ET: Statistical Methods for Survival Analysis. New York, John Wiley & Sons, 1992
16. ROTHMAN KJ: Modern Epidemiology. Boston, Little, Brown, 1986
17. MATSUSHIMA M, TAJIMA N, LAPORTE RE, ORCHARD TJ, TULL ES, GOWER ID, KITAGAWA T, FOR THE DIABETES EPIDEMIOLOGY RESEARCH INTERNATIONAL (DERI) U.S.-JAPAN MORTALITY STUDY GROUP: Markedly increased renal disease mortality and incidence of renal replacement therapy among IDDM patients in Japan in contrast to Allegheny County, Pennsylvania, USA. Diabetologia 38:236-243, 1995
18. COWIE CC, PORT FK, WOLFE RA, SAVAGE PJ, MOLL PP, HAWTHORNE VM: Disparities in the incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med 231:1074-10911, 1989
19. KROLEWSKI AS, LAFFEL LMB, KROLEWSKI M, QUINN M, WARRAM JH: Glycated hemoglobin and risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 332:1251-1255, 1995
20. BOJESTIG M, ARNQVIST HJ, HERMANSSON G, KARIBERG BE, LUDVIGSSON J: Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 330:15-18, 1993
21. BORCH-JOHNSEN K, KREINER S, DECKERT T: Diabetic nephropathy - Susceptible to care? A cohort-study of 641 patients with type 1 (insulin-dependent) diabetes. Diabetes Res 3:397-400, 1986
22. JACOBSON AM, ADLER A, DERBY L, ANDERSON B, WOLDSDORF J: Clinic attendance and glycemic control: A study of contrasting groups of patients with insulin-dependent diabetes mellitus. Diabetes Care 14:599-601, 1991
23. JACOBSON AM, HAUSER AT, WILLET J, WOLFSDORF JI, HERMAN L: Contexts and consequences of irregular versus continuous medical follow-up: A prospective study of children and adolescents with insulin-dependent diabetes mellitus. (Submitted for publication)
24. WARRAM JH, LAFFEL LMB, GANDA OP, CHRISTLIEB AR: Coronary artery disease is the major determinant of excess mortality in patients with insulin-dependent diabetes mellitus and persistent proteinuria. J Am Soc Nephrol 3:S104-S110, 1992